{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:31:10Z","timestamp":1793467870286,"version":"4.5.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40261-026-01599-z","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:24:46Z","timestamp":1791041086000},"page":"1239-1253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serotonergic Toxicity and Hyponatremia Associated with Antidepressant Therapy: The Pivotal Role of SIADH"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6473-7632","authenticated-orcid":false,"given":"Donato","family":"Morena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Biso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Turillazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Fineschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"1599_CR1","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJMra041867","volume":"352","author":"EW Boyer","year":"2005","unstructured":"Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112\u201320.","journal-title":"N Engl J Med"},{"key":"1599_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3949\/ccjm.83a.15129","volume":"83","author":"RZ Wang","year":"2016","unstructured":"Wang RZ, Vashistha V, Kaur S, Houchens NW. Serotonin syndrome: preventing, recognizing, and treating it. Cleve Clin J Med. 2016;83:810\u20137.","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"1599_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/15563650.2022.2151455","volume":"61","author":"J Cooper","year":"2023","unstructured":"Cooper J, Duffull SB, Isbister GK. Predicting serotonin toxicity in serotonin reuptake inhibitor overdose. Clin Toxicol. 2023;61(1):22\u20138.","journal-title":"Clin Toxicol"},{"key":"1599_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/15563650.2021.1993242","volume":"60","author":"AL Chiew","year":"2022","unstructured":"Chiew AL, Buckley NA. The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes. Clin Toxicol. 2022;60:143\u201358.","journal-title":"Clin Toxicol"},{"key":"1599_CR5","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/hup.918","volume":"23","author":"PM Haddad","year":"2007","unstructured":"Haddad PM, Dursun SM. Neurological complications of psychiatric drugs: clinical features and management. Hum Psychopharmacol Clin Exp. 2007;23:S15-26.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"1599_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cpem.2005.04.009","volume":"6","author":"M Ganetsky","year":"2005","unstructured":"Ganetsky M, Brush DE. Serotonin syndrome\u2014what have we learned? Clin Pediatr Emerg Med. 2005;6:103\u20138.","journal-title":"Clin Pediatr Emerg Med."},{"key":"1599_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00005792-200007000-00001","volume":"79","author":"PJ Mason","year":"2000","unstructured":"Mason PJ, Morris VA, Balcezak TJ. Serotonin syndrome presentation of 2 cases and review of the literature. Medicine (Baltimore). 2000;79:201\u20139.","journal-title":"Medicine (Baltimore)"},{"key":"1599_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","volume":"96","author":"EJC Dunkley","year":"2003","unstructured":"Dunkley EJC, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96:635\u201342.","journal-title":"QJM"},{"key":"1599_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00005792-197905000-00004","volume":"58","author":"CR Cooke","year":"1979","unstructured":"Cooke CR, Turin MD, Walker WG. The syndrome of inappropriate antidiuretic hormone secretion (SIADH). Medicine (Baltimore). 1979;58:240\u201351.","journal-title":"Medicine (Baltimore)"},{"key":"1599_CR10","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1056\/NEJMoa042743","volume":"352","author":"BJ Feldman","year":"2005","unstructured":"Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, et al. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med. 2005;352:1884\u201390.","journal-title":"N Engl J Med"},{"key":"1599_CR11","first-page":"519","volume":"155","author":"BA Liu","year":"1996","unstructured":"Liu BA, Mittmann N, Knowles SR, Shear NH. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. CMAJ Can Med Assoc J. 1996;155:519.","journal-title":"CMAJ Can Med Assoc J"},{"key":"1599_CR12","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/ndt\/gfu040","volume":"29","author":"G Spasovski","year":"2014","unstructured":"Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant. 2014;29:i1-39.","journal-title":"Nephrol Dial Transplant"},{"key":"1599_CR13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/0002-9343(67)90096-4","volume":"42","author":"FC Bartter","year":"1967","unstructured":"Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967;42:790\u2013806.","journal-title":"Am J Med"},{"key":"1599_CR14","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1681\/ASN.2016101139","volume":"28","author":"EJ Hoorn","year":"2017","unstructured":"Hoorn EJ, Zietse R. Diagnosis and treatment of hyponatremia: compilation of the guidelines. J Am Soc Nephrol. 2017;28:1340\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"1599_CR15","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.926561","volume":"21","author":"C-Y Chiu","year":"2020","unstructured":"Chiu C-Y, Sarwal A, Munir RA, Widjaja M, Khalid A, Khanna R. Syndrome of inappropriate antidiuretic hormone (SIADH) induced by long-term use of citalopram and short-term use of naproxen. Am J Case Rep. 2020;21:e926561.","journal-title":"Am J Case Rep"},{"key":"1599_CR16","first-page":"92","volume":"03","author":"ME Choudhry","year":"2014","unstructured":"Choudhry ME. Serotonin syndrome and acute hyponatremia, complex overlapping syndromes, a case report and review. Case Rep Clin Med. 2014;03:92\u20136.","journal-title":"Case Rep Clin Med"},{"key":"1599_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195810","volume":"11","author":"G-H Kim","year":"2022","unstructured":"Kim G-H. Pathophysiology of drug-induced hyponatremia. J Clin Med. 2022;11:5810.","journal-title":"J Clin Med"},{"key":"1599_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s004240100604","volume":"442","author":"R Franco","year":"2001","unstructured":"Franco R, Torres-Marquez M, Pasantes-Morales H. Evidence for two mechanisms of amino acid osmolyte release from hippocampal slices. Pfluegers Archiv Eur J Physiol. 2001;442:791\u2013800.","journal-title":"Pfluegers Archiv Eur J Physiol"},{"key":"1599_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/20451253251406044","volume":"16","author":"D Morena","year":"2026","unstructured":"Morena D, Colonna SS, Santurro A, Scopetti M, Tortorella A, Fineschi V. The interplay between serotonin syndrome and syndrome of inappropriate antidiuresis: a fatal case of acute hyponatremia during treatment with duloxetine, chlorphenamine, amitriptyline, and L-tryptophan. Ther Adv Psychopharmacol. 2026;16:20451253251406044.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"4","key":"1599_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1179\/2047480615Z.000000000329","volume":"24","author":"R Ferrari","year":"2015","unstructured":"Ferrari R. Writing narrative style literature reviews. Med Writ. 2015;24(4):230\u20135.","journal-title":"Med Writ"},{"issue":"9","key":"1599_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092288","volume":"20","author":"J Francescangeli","year":"2019","unstructured":"Francescangeli J, Karamchandani K, Powell M, Bonavia A. The serotonin syndrome: from molecular mechanisms to clinical practice. Int J Mol Sci. 2019;20(9):2288.","journal-title":"Int J Mol Sci"},{"key":"1599_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neulet.2012.08.083","volume":"528","author":"K Shioda","year":"2012","unstructured":"Shioda K, Nisijima K, Kasai M, Yoshino T, Kato S. Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models. Neurosci Lett. 2012;528:22\u20136.","journal-title":"Neurosci Lett"},{"key":"1599_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.neuropharm.2007.07.009","volume":"53","author":"M Fox","year":"2007","unstructured":"Fox M, Jensen C, Gallagher P, Murphy D. Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice. Neuropharmacology. 2007;53:643\u201356.","journal-title":"Neuropharmacology"},{"issue":"10","key":"1599_CR24","first-page":"452","volume":"37","author":"CW Talton","year":"2020","unstructured":"Talton CW. Serotonin syndrome\/serotonin toxicity. Fed Pract. 2020;37(10):452\u20139.","journal-title":"Fed Pract"},{"key":"1599_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5498\/wjp.v11.i4.124","volume":"11","author":"S Prakash","year":"2021","unstructured":"Prakash S, Rathore C, Rana K, Roychowdhury D, Lodha D. Chronic serotonin syndrome: a retrospective study. World J Psychiatry. 2021;11:124\u201332.","journal-title":"World J Psychiatry"},{"key":"1599_CR26","volume-title":"Serotonin syndrome","author":"LV Simon","year":"2025","unstructured":"Simon LV, Keenaghan M. Serotonin syndrome. Treasure Island: StatPearls Publishing; 2025."},{"key":"1599_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1054\/mehy.2000.1047","volume":"55","author":"JW Radomski","year":"2000","unstructured":"Radomski JW, Dursun SM, Reveley MA, Kutcher SP. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses. 2000;55:218\u201324.","journal-title":"Med Hypotheses"},{"key":"1599_CR28","doi-asserted-by":"publisher","first-page":"g1626","DOI":"10.1136\/bmj.g1626","volume":"348","author":"NA Buckley","year":"2014","unstructured":"Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ. 2014;348:g1626.","journal-title":"BMJ"},{"key":"1599_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/104012371202400410","volume":"24","author":"MM Iqbal","year":"2012","unstructured":"Iqbal MM, Basil MJ, Kaplan J, Iqbal MT. Overview of serotonin syndrome. Ann Clin Psychiatry. 2012;24:310\u20138.","journal-title":"Ann Clin Psychiatry"},{"key":"1599_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/00207450108986532","volume":"109","author":"Y Kaneda","year":"2001","unstructured":"Kaneda Y, Ishimoto Y, Ohmori T. Mild serotonin syndrome on fluvoxamine. Int J Neurosci. 2001;109:165\u201372.","journal-title":"Int J Neurosci"},{"key":"1599_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4103\/0972-2327.150612","volume":"18","author":"S Prakash","year":"2015","unstructured":"Prakash S, Patel V, Kakked S, Patel I, Yadav R. Mild serotonin syndrome: a report of 12 cases. Ann Indian Acad Neurol. 2015;18:226.","journal-title":"Ann Indian Acad Neurol"},{"key":"1599_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jfcm.jfcm_236_23","volume":"31","author":"A Badar","year":"2024","unstructured":"Badar A. Serotonin syndrome: an often-neglected medical emergency. J Fam Community Med. 2024;31:1.","journal-title":"J Fam Community Med"},{"key":"1599_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/2045125318818814","volume":"9","author":"M Ott","year":"2019","unstructured":"Ott M, Mannchen JK, Jamshidi F, Werneke U. Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques. Ther Adv Psychopharmacol. 2019;9:204512531881881.","journal-title":"Ther Adv Psychopharmacol"},{"key":"1599_CR34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1517\/14740338.7.5.587","volume":"7","author":"C Sun-Edelstein","year":"2008","unstructured":"Sun-Edelstein C, Tepper SJ, Shapiro RE. Drug-induced serotonin syndrome: a review. Expert Opin Drug Saf. 2008;7:587\u201396.","journal-title":"Expert Opin Drug Saf"},{"key":"1599_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.wnf.0000177642.89888.85","volume":"28","author":"GK Isbister","year":"2005","unstructured":"Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans. Clin Neuropharmacol. 2005;28:205\u201314.","journal-title":"Clin Neuropharmacol"},{"key":"1599_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/0897190019841742","volume":"33","author":"TR Hudd","year":"2019","unstructured":"Hudd TR, Blake CS, Rimola-Dejesus Y, Nguyen T-T, Zaiken K. A case report of serotonin syndrome in a patient on selective serotonin reuptake inhibitor (SSRI) monotherapy. J Pharm Pract. 2019;33:206\u201312.","journal-title":"J Pharm Pract"},{"key":"1599_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/026988119901300111","volume":"13","author":"PK Gillman","year":"1999","unstructured":"Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol. 1999;13:100\u20139.","journal-title":"J Psychopharmacol"},{"key":"1599_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1526-4610.2009.01575.x","volume":"50","author":"PK Gillman","year":"2010","unstructured":"Gillman PK. Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review. Headache. 2010;50:264\u201372.","journal-title":"Headache"},{"key":"1599_CR39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/jac\/dkh404","volume":"54","author":"PK Gillman","year":"2004","unstructured":"Gillman PK. Comment on: serotonin syndrome due to co-administration of linezolid and venlafaxine. J Antimicrob Chemother. 2004;54:844\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"1599_CR40","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.biopsych.2003.07.006","volume":"55","author":"SN Vaishnavi","year":"2004","unstructured":"Vaishnavi SN, Nemeroff CB, Plott SJ, Rao SG, Kranzler J, Owens MJ. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry. 2004;55:320\u20132.","journal-title":"Biol Psychiatry"},{"key":"1599_CR41","unstructured":"National Library of Medicine. DailyMed. FETZIMA (levomilnacipran hydrochloride) extended-release capsules, prescribing information. 2024. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=f371258d-91b3-4b6a-ac99-434a1964c3af. Accessed 04 Aug 2026."},{"key":"1599_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0616-1","volume":"16","author":"U Werneke","year":"2016","unstructured":"Werneke U, Jamshidi F, Taylor DM, Ott M. Conundrums in neurology: diagnosing serotonin syndrome\u2014a meta-analysis of cases. BMC Neurol. 2016;16:97.","journal-title":"BMC Neurol"},{"key":"1599_CR43","unstructured":"National Library of Medicine. DailyMed: TRINTELLIX (vortioxetine) tablets, prescribing information. 2025. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=1a5b68e2-14d0-419d-9ec6-1ca97145e838. Accessed 04 Aug 2026."},{"key":"1599_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/00002826-200303000-00002","volume":"26","author":"EE Ubogu","year":"2003","unstructured":"Ubogu EE, Katirji B. Mirtazapine-induced serotonin syndrome. Clin Neuropharmacol. 2003;26:54\u20137.","journal-title":"Clin Neuropharmacol"},{"key":"1599_CR45","doi-asserted-by":"publisher","first-page":"301.e9","DOI":"10.1016\/j.genhosppsych.2010.11.015","volume":"33","author":"BD Poeschla","year":"2011","unstructured":"Poeschla BD, Bartle P, Hansen KP. Serotonin syndrome associated with polypharmacy in the elderly. Gen Hosp Psychiatry. 2011;33:301.e9-11.","journal-title":"Gen Hosp Psychiatry"},{"key":"1599_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00213-013-3024-x","volume":"228","author":"V Gigliucci","year":"2013","unstructured":"Gigliucci V, O\u2019Dowd G, Casey S, Egan D, Gibney S, Harkin A. Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology. 2013;228:157\u201366.","journal-title":"Psychopharmacology"},{"key":"1599_CR47","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/npp.2015.233","volume":"41","author":"K Fukumoto","year":"2015","unstructured":"Fukumoto K, Iijima M, Chaki S. The antidepressant effects of an mGlu2\/3 receptor antagonist and ketamine require AMPA receptor stimulation in the mPFC and subsequent activation of the 5-HT neurons in the DRN. Neuropsychopharmacology. 2015;41:1046\u201356.","journal-title":"Neuropsychopharmacology"},{"key":"1599_CR48","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1021\/acschemneuro.9b00288","volume":"10","author":"X Lopez-Gil","year":"2019","unstructured":"Lopez-Gil X, Jimenez-Sanchez L, Campa L, Castro E, Frago C, Adell A. Role of serotonin and noradrenaline in the rapid antidepressant action of ketamine. ACS Chem Neurosci. 2019;10:3318\u201326.","journal-title":"ACS Chem Neurosci"},{"key":"1599_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaf367","volume":"12","author":"H Luo","year":"2025","unstructured":"Luo H, Chen M, Ning Y, Ren L, Lu Y, Sun J, et al. Inhibition of SERT and NMDAR synergistically confers rapid antidepressant effects of ketamine. Natl Sci Rev. 2025;12:nwaf367.","journal-title":"Natl Sci Rev"},{"key":"1599_CR50","first-page":"e1","volume":"19","author":"C Gueits","year":"2020","unstructured":"Gueits C, Witkin M. Ketamine and serotonin syndrome: a case report. Current Psychiatry. 2020;19:e1-2.","journal-title":"Current Psychiatry"},{"key":"1599_CR51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/PRA.0000000000000787","volume":"30","author":"A Deka","year":"2024","unstructured":"Deka A, Joseph E, Sharma N, Berhanu T, Kaplan J. Recurrent serotonin syndrome after ketamine-assisted electroconvulsive therapy: a case report and review of the literature. J Psychiatr Pract. 2024;30:234\u201341.","journal-title":"J Psychiatr Pract"},{"key":"1599_CR52","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrn2884","volume":"11","author":"FX Vollenweider","year":"2010","unstructured":"Vollenweider FX, Kometer M. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci. 2010;11:642\u201351.","journal-title":"Nat Rev Neurosci"},{"key":"1599_CR53","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00213-021-05876-x","volume":"239","author":"B Malcolm","year":"2022","unstructured":"Malcolm B, Thomas K. Serotonin toxicity of serotonergic psychedelics. Psychopharmacology. 2022;239:1881\u201391.","journal-title":"Psychopharmacology"},{"issue":"10","key":"1599_CR54","volume":"14","author":"DB Goel","year":"2022","unstructured":"Goel DB, Zilate S. Potential therapeutic effects of psilocybin: a systematic review. Cureus. 2022;14(10):e30214.","journal-title":"Cureus"},{"key":"1599_CR55","volume":"26","author":"AD Amarnani","year":"2024","unstructured":"Amarnani AD, Free MF, Baweja R. Psilocybin and the development of serotonin toxicity. Prim Care Companion CNS Disord. 2024;26:52347.","journal-title":"Prim Care Companion CNS Disord"},{"key":"1599_CR56","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","volume":"26","author":"A Rickli","year":"2016","unstructured":"Rickli A, Moning OD, Hoener MC, Liechti ME. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. Eur Neuropsychopharmacol. 2016;26:1327\u201337.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"1599_CR57","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/10600280231205645","volume":"58","author":"D Kaminski","year":"2024","unstructured":"Kaminski D, Reinert JP. The tolerability and safety of psilocybin in psychiatric and substance-dependence conditions: a systematic review. Ann Pharmacother. 2024;58(8):811\u201326.","journal-title":"Ann Pharmacother"},{"issue":"10","key":"1599_CR58","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1177\/02698811221116926","volume":"36","author":"JJ Breeksema","year":"2022","unstructured":"Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. Adverse events in clinical treatments with serotonergic psychedelics and MDMA: a mixed-methods systematic review. J Psychopharmacol. 2022;36(10):1100\u201317.","journal-title":"J Psychopharmacol"},{"key":"1599_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113638","volume":"339","author":"F Schifano","year":"2021","unstructured":"Schifano F, Chiappini S, Miuli A, Corkery JM, Scherbaum N, Napoletano F, et al. New psychoactive substances (NPS) and serotonin syndrome onset: a systematic review. Exp Neurol. 2021;339:113638.","journal-title":"Exp Neurol"},{"key":"1599_CR60","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1345\/aph.1Q748","volume":"46","author":"EM Nelson","year":"2012","unstructured":"Nelson EM, Philbrick AM. Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors. Ann Pharmacother. 2012;46:1712\u20136.","journal-title":"Ann Pharmacother"},{"key":"1599_CR61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bja.2019.08.010","volume":"124","author":"BA Baldo","year":"2020","unstructured":"Baldo BA, Rose MA. The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review. Br J Anaesth. 2020;124:44\u201362.","journal-title":"Br J Anaesth"},{"key":"1599_CR62","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/15563650701668625","volume":"46","author":"AR Schwartz","year":"2008","unstructured":"Schwartz AR, Pizon AF, Brooks DE. Dextromethorphan-induced serotonin syndrome. Clin Toxicol. 2008;46:771\u20133.","journal-title":"Clin Toxicol"},{"key":"1599_CR63","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1447-0594.2010.00652.x","volume":"11","author":"H Kinoshita","year":"2010","unstructured":"Kinoshita H, Ohkubo T, Yasuda M, Yakushiji F. Serotonin syndrome induced by dextromethorphan (Medicon) administrated at the conventional dose. Geriatr Gerontol Int. 2010;11:121\u20132.","journal-title":"Geriatr Gerontol Int"},{"key":"1599_CR64","doi-asserted-by":"publisher","first-page":"719","DOI":"10.31083\/j.jin.2020.04.314","volume":"19","author":"U Werneke","year":"2020","unstructured":"Werneke U, Truedson-Martiniussen P, Wikstrom H, Ott M. Serotonin syndrome: a clinical review of current controversies. J Integr Neurosci. 2020;19:719.","journal-title":"J Integr Neurosci"},{"key":"1599_CR65","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jamaneurol.2017.5144","volume":"75","author":"Y Orlova","year":"2018","unstructured":"Orlova Y, Rizzoli P, Loder E. Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome. JAMA Neurol. 2018;75:566\u201372.","journal-title":"JAMA Neurol"},{"issue":"4","key":"1599_CR66","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1208\/s12248-009-9146-8","volume":"11","author":"F Borrelli","year":"2009","unstructured":"Borrelli F, Izzo AA. Herb\u2013drug interactions with St John\u2019s wort (Hypericum perforatum): an update on clinical observations. AAPS J. 2009;11(4):710\u201327.","journal-title":"AAPS J"},{"key":"1599_CR67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00004850-199701000-00010","volume":"12","author":"O Spigset","year":"1997","unstructured":"Spigset O, Adielsson G. Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction. Int Clin Psychopharmacol. 1997;12:61.","journal-title":"Int Clin Psychopharmacol"},{"key":"1599_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd000448.pub3","author":"K Linde","year":"2008","unstructured":"Linde K, Berner MM, Kriston L. St John\u2019s wort for major depression. Cochrane Database Syst Rev. 2008. https:\/\/doi.org\/10.1002\/14651858.cd000448.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"1599_CR69","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1211\/0022357011775910","volume":"53","author":"J Barnes","year":"2001","unstructured":"Barnes J, Anderson LA, Phillipson JD. St John\u2019s wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2001;53:583\u2013600.","journal-title":"J Pharm Pharmacol"},{"key":"1599_CR70","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2165\/00002018-200427110-00003","volume":"27","author":"M Mannel","year":"2004","unstructured":"Mannel M. Drug interactions with St John\u2019s wort. Drug Saf. 2004;27:773\u201397.","journal-title":"Drug Saf"},{"key":"1599_CR71","first-page":"950","volume":"57","author":"JB Gordon","year":"1998","unstructured":"Gordon JB. SSRIs and St. John\u2019s wort: possible toxicity? Am Fam Physician. 1998;57:950\u20133.","journal-title":"Am Fam Physician"},{"key":"1599_CR72","doi-asserted-by":"publisher","first-page":"983","DOI":"10.12740\/PP\/OnlineFirst\/80998","volume":"52","author":"J Woron","year":"2018","unstructured":"Woron J, Siwek M. Unwanted effects of psychotropic drug interactions with medicinal products and diet supplements containing plant extracts. Psychiatr Pol. 2018;52:983\u201396.","journal-title":"Psychiatr Pol"},{"key":"1599_CR73","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/j.1468-2982.2007.01430.x","volume":"27","author":"N Bonetto","year":"2007","unstructured":"Bonetto N, Santelli L, Battistin L, Cagnin A. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum. Cephalalgia. 2007;27:1421\u20133.","journal-title":"Cephalalgia"},{"key":"1599_CR74","first-page":"1285","volume":"29","author":"N Prost","year":"2000","unstructured":"Prost N, Tichadou L, Rodor F, Nguyen N, David JM, Jean-Pastor MJ. St. John\u2019s wort\u2013venlafaxine interaction. Presse Med. 2000;29:1285\u20136.","journal-title":"Presse Med"},{"key":"1599_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s002130000397","volume":"150","author":"K Nisijima","year":"2000","unstructured":"Nisijima K, Yoshino T, Ishiguro T. Risperidone counteracts lethality in an animal model of the serotonin syndrome. Psychopharmacology. 2000;150:9\u201314.","journal-title":"Psychopharmacology"},{"key":"1599_CR76","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.medcli.2015.03.010","volume":"145","author":"MI Ostabal Artigas","year":"2015","unstructured":"Ostabal Artigas MI. Sindrome serotoninergico por interaccion entre linezolid y 5-hidroxitriptofano. Med Clin. 2015;145:e37\u20138.","journal-title":"Med Clin"},{"key":"1599_CR77","doi-asserted-by":"publisher","first-page":"926","DOI":"10.12659\/AJCR.904375","volume":"18","author":"YA Patel","year":"2017","unstructured":"Patel YA, Marzella N. Dietary supplement\u2013drug interaction-induced serotonin syndrome progressing to acute compartment syndrome. Am J Case Rep. 2017;18:926\u201330.","journal-title":"Am J Case Rep"},{"key":"1599_CR78","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jad.2010.06.010","volume":"130","author":"N Iovieno","year":"2011","unstructured":"Iovieno N, Dalton ED, Fava M, Mischoulon D. Second-tier natural antidepressants: review and critique. J Affect Disord. 2011;130:343\u201357.","journal-title":"J Affect Disord"},{"key":"1599_CR79","first-page":"1","volume":"18","author":"AM Kikuchi","year":"2020","unstructured":"Kikuchi AM, Tanabe A, Iwahori Y. A systematic review of the effect of l-tryptophan supplementation on mood and emotional functioning. J Diet Suppl. 2020;18:1\u201318.","journal-title":"J Diet Suppl"},{"key":"1599_CR80","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3177\/jnsv.65.507","volume":"65","author":"N Tsujita","year":"2019","unstructured":"Tsujita N, Akamatsu Y, Nishida MM, Hayashi T, Moritani T. Effect of tryptophan, vitamin B6, and nicotinamide-containing supplement loading between meals on mood and autonomic nervous system activity in young adults with subclinical depression: a randomized, double-blind, and placebo-controlled study. J Nutr Sci Vitaminol. 2019;65:507\u201314.","journal-title":"J Nutr Sci Vitaminol"},{"key":"1599_CR81","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ajem.2004.09.013","volume":"22","author":"SM Bryant","year":"2004","unstructured":"Bryant SM, Kolodchak J. Serotonin syndrome resulting from an herbal detox cocktail. Am J Emerg Med. 2004;22:625\u20136.","journal-title":"Am J Emerg Med"},{"key":"1599_CR82","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12991-020-00298-z","volume":"19","author":"A Cuomo","year":"2020","unstructured":"Cuomo A, Beccarini Crescenzi B, Bolognesi S, Goracci A, Koukouna D, Rossi R, et al. S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review. Ann Gen Psychiatry. 2020;19:50.","journal-title":"Ann Gen Psychiatry"},{"key":"1599_CR83","doi-asserted-by":"publisher","first-page":"1151S","DOI":"10.1093\/ajcn\/76.5.1151S","volume":"76","author":"T Bottiglieri","year":"2002","unstructured":"Bottiglieri T. S-Adenosyl-l-methionine (SAMe): from the bench to the bedside\u2014molecular basis of a pleiotrophic molecule. Am J Clin Nutr. 2002;76:1151S-S1157.","journal-title":"Am J Clin Nutr"},{"key":"1599_CR84","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1365-2125.2010.03747.x","volume":"70","author":"AA Monte","year":"2010","unstructured":"Monte AA, Chuang R, Bodmer M. Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review. Br J Clin Pharmacol. 2010;70:794\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"1599_CR85","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1210\/clinem\/dgac245","volume":"107","author":"J Martin-Grace","year":"2022","unstructured":"Martin-Grace J, Tomkins M, O\u2019Reilly MW, Thompson CJ, Sherlock M. Approach to the patient: hyponatremia and the syndrome of inappropriate antidiuresis (SIAD). J Clin Endocrinol Metab. 2022;107:2362\u201376.","journal-title":"J Clin Endocrinol Metab"},{"key":"1599_CR86","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40619-023-01298-3","volume":"24","author":"E Varaldo","year":"2023","unstructured":"Varaldo E, Berton AM, Prencipe N, Benso A. Gestione dell\u2019iponatriemia acuta in ambiente ospedaliero. L\u2019Endocrinologo. 2023;24:35\u20137.","journal-title":"L'Endocrinologo"},{"key":"1599_CR87","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00005792-197603000-00002","volume":"55","author":"AI Arieff","year":"1976","unstructured":"Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine. 1976;55:121\u20139.","journal-title":"Medicine"},{"key":"1599_CR88","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11910-015-0536-2","volume":"15","author":"MA Podesta","year":"2015","unstructured":"Podesta MA, Faravelli I, Cucchiari D, Reggiani F, Oldani S, Fedeli C, et al. Neurological counterparts of hyponatremia: pathological mechanisms and clinical manifestations. Curr Neurol Neurosci Rep. 2015;15:18.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1599_CR89","doi-asserted-by":"publisher","first-page":"711","DOI":"10.7326\/0003-4819-132-9-200005020-00005","volume":"132","author":"JC Ayus","year":"2000","unstructured":"Ayus JC, Varon J, Arieff AI. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711.","journal-title":"Ann Intern Med"},{"key":"1599_CR90","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1172\/JCI102501","volume":"30","author":"MB Strauss","year":"1951","unstructured":"Strauss MB, Davis RK, Rosenbaum JD, Rossmeisl EC. \u201cWater diuresis\u201d produced during recumbency by the intravenous infusion of isotonic saline solution. J Clin Investig. 1951;30:862\u20138.","journal-title":"J Clin Investig"},{"key":"1599_CR91","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.amjmed.2009.01.027","volume":"122","author":"SS Waikar","year":"2009","unstructured":"Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122:857\u201365.","journal-title":"Am J Med"},{"key":"1599_CR92","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0733-8627(20)30315-1","volume":"7","author":"SR Votey","year":"1989","unstructured":"Votey SR, Peters AL, Hoffman JR. Disorders of water metabolism: hyponatremia and hypernatremia. Emerg Med Clin North Am. 1989;7:749\u201369.","journal-title":"Emerg Med Clin North Am"},{"key":"1599_CR93","first-page":"2387","volume":"69","author":"KP Goh","year":"2004","unstructured":"Goh KP. Management of hyponatremia. Am Fam Physician. 2004;69:2387\u201394.","journal-title":"Am Fam Physician"},{"key":"1599_CR94","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2165\/00002018-199512030-00006","volume":"12","author":"O Spigset","year":"1995","unstructured":"Spigset O, Hedenmalm K. Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Saf. 1995;12:209\u201325.","journal-title":"Drug Saf"},{"key":"1599_CR95","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","volume":"126","author":"JG Verbalis","year":"2013","unstructured":"Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126:S1-42.","journal-title":"Am J Med"},{"key":"1599_CR96","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","volume":"342","author":"HJ Adrogue","year":"2000","unstructured":"Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581\u20139.","journal-title":"N Engl J Med"},{"key":"1599_CR97","doi-asserted-by":"publisher","first-page":"891","DOI":"10.7326\/0003-4819-117-11-891","volume":"117","author":"JC Ayus","year":"1992","unstructured":"Ayus JC. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med. 1992;117:891.","journal-title":"Ann Intern Med"},{"key":"1599_CR98","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/ndt\/gfg394","volume":"18","author":"ML Moritz","year":"2003","unstructured":"Moritz ML, Ayus JC. The pathophysiology and treatment of hyponatraemic encephalopathy: an update. Nephrol Dial Transplant. 2003;18:2486\u201391.","journal-title":"Nephrol Dial Transplant"},{"key":"1599_CR99","doi-asserted-by":"publisher","first-page":"F305","DOI":"10.1152\/ajprenal.00685.2014","volume":"309","author":"MU Cheema","year":"2015","unstructured":"Cheema MU, Irsik DL, Wang Y, Miller-Little WA, Hyndman KA, Marks E, et al. Estradiol regulates AQP2 expression in the collecting duct: a novel inhibitory role for estrogen receptor alpha. Am J Physiol Renal Physiol. 2015;309:F305\u201317.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1599_CR100","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mcn.2006.09.008","volume":"34","author":"X-N Zeng","year":"2007","unstructured":"Zeng X-N, Sun X-L, Gao L, Fan Y, Ding J-H, Hu G. Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol Cell Neurosci. 2007;34:34\u20139.","journal-title":"Mol Cell Neurosci"},{"key":"1599_CR101","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bbagen.2009.10.002","volume":"1800","author":"M-A Arevalo","year":"2010","unstructured":"Arevalo M-A, Santos-Galindo M, Bellini M-J, Azcoitia I, Garcia-Segura LM. Actions of estrogens on glial cells: implications for neuroprotection. Biochim Biophys Acta (BBA) Gen Subj. 2010;1800:1106\u201312.","journal-title":"Biochim Biophys Acta (BBA) Gen Subj"},{"key":"1599_CR102","doi-asserted-by":"publisher","first-page":"461.e11","DOI":"10.1016\/j.amjmed.2006.10.027","volume":"120","author":"AJ Siegel","year":"2007","unstructured":"Siegel AJ, Verbalis JG, Clement S, Mendelson JH, Mello NK, Adner M, et al. Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. Am J Med. 2007;120:461.e11-7.","journal-title":"Am J Med"},{"key":"1599_CR103","doi-asserted-by":"publisher","first-page":"C204","DOI":"10.1152\/ajpcell.00399.2010","volume":"301","author":"JM Rutkowsky","year":"2011","unstructured":"Rutkowsky JM, Wallace BK, Wise PM, O\u2019Donnell ME. Effects of estradiol on ischemic factor-induced astrocyte swelling and AQP4 protein abundance. Am J Physiol Cell Physiol. 2011;301:C204\u201312.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1599_CR104","first-page":"114","volume":"32","author":"SJ Park","year":"2012","unstructured":"Park SJ, Pai KS, Kim JH, Shin JI. The role of interleukin 6 in the pathogenesis of hyponatremia associated with Guillain-Barre syndrome. Nefrologia. 2012;32:114.","journal-title":"Nefrologia"},{"key":"1599_CR105","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/archneurpsyc.1959.02340140020004","volume":"81","author":"RD Adams","year":"1959","unstructured":"Adams RD. Central pontine myelinolysis. AMA Arch Neurol Psychiatry. 1959;81:154.","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"1599_CR106","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12883-024-03934-3","volume":"24","author":"B Treves","year":"2024","unstructured":"Treves B, Consalvo F, Delogu G, Morena D, Padovano M, Santurro A, et al. Osmotic demyelination syndrome: revisiting the diagnostic criteria through two fatal cases. BMC Neurol. 2024;24:428.","journal-title":"BMC Neurol"},{"key":"1599_CR107","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ndt\/gfi082","volume":"21","author":"EJ Hoorn","year":"2005","unstructured":"Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant. 2005;21:70\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"1599_CR108","doi-asserted-by":"publisher","first-page":"150","DOI":"10.12659\/AJCR.896572","volume":"17","author":"AJ Siegel","year":"2016","unstructured":"Siegel AJ, Forte SS, Bhatti NA, Gelda SE. Drug-related hyponatremic encephalopathy: rapid clinical response averts life-threatening acute cerebral edema. Am J Case Rep. 2016;17:150\u20133.","journal-title":"Am J Case Rep"},{"key":"1599_CR109","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2125.1999.00872.x","volume":"47","author":"TJ Wilkinson","year":"1999","unstructured":"Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999;47:211\u20137.","journal-title":"Br J Clin Pharmacol"},{"key":"1599_CR110","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.psym.2014.01.010","volume":"55","author":"L De Picker","year":"2014","unstructured":"De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BGC. Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics. 2014;55:536\u201347.","journal-title":"Psychosomatics"},{"issue":"1","key":"1599_CR111","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2024.11","volume":"67","author":"T Gheysens","year":"2024","unstructured":"Gheysens T, Van Den Eede F, De Picker L. The risk of antidepressant-induced hyponatremia: a meta-analysis of antidepressant classes and compounds. Eur Psychiatry. 2024;67(1):e20.","journal-title":"Eur Psychiatry"},{"key":"1599_CR112","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1099-1166(199801)13:1<12::AID-GPS718>3.0.CO;2-F","volume":"13","author":"WP Bouman","year":"1998","unstructured":"Bouman WP, Pinner G, Johnson H. Incidence of selective serotonin reuptake inhibitor (SSRI) induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly. Int J Geriatr Psychiatry. 1998;13:12\u20135.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1599_CR113","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1111\/bcp.13256","volume":"83","author":"D Shepshelovich","year":"2017","unstructured":"Shepshelovich D, Schechter A, Calvarysky B, Diker-Cohen T, Rozen-Zvi B, Gafter-Gvili A. Medication-induced SIADH: distribution and characterization according to medication class. Br J Clin Pharmacol. 2017;83:1801\u20137.","journal-title":"Br J Clin Pharmacol"},{"key":"1599_CR114","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/106002809703100117","volume":"31","author":"MH Woo","year":"1997","unstructured":"Woo MH, Smythe MA. Association of SIADH with selective serotonin reuptake inhibitors. Ann Pharmacother. 1997;31:108\u201310.","journal-title":"Ann Pharmacother"},{"issue":"8","key":"1599_CR115","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s40618-025-02587-4","volume":"48","author":"D Norello","year":"2025","unstructured":"Norello D, Defazio G, Corona G, Caiulo C, Maggi M, Peri A. Treatment with antidepressant drugs and hyponatremia: a network meta-analysis. J Endocrinol Invest. 2025;48(8):1707\u201315.","journal-title":"J Endocrinol Invest"},{"key":"1599_CR116","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1345\/aph.1C071","volume":"36","author":"TS Barclay","year":"2002","unstructured":"Barclay TS, Lee AJ. Citalopram-associated SIADH. Ann Pharmacother. 2002;36:1558\u201363.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1599_CR117","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1055\/s-2007-979293","volume":"31","author":"VP Leung","year":"1998","unstructured":"Leung VP, Chiu HF, Lam LC. Hyponatremia associated with paroxetine. Pharmacopsychiatry. 1998;31(1):32\u20134.","journal-title":"Pharmacopsychiatry"},{"key":"1599_CR118","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1345\/aph.1G293","volume":"40","author":"S Jacob","year":"2006","unstructured":"Jacob S, Spinier SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006;40:1618\u201322.","journal-title":"Ann Pharmacother"},{"key":"1599_CR119","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/archinte.164.3.327","volume":"164","author":"TJ Fabian","year":"2004","unstructured":"Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Corey SE, Begley AE, et al. Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Arch Intern Med. 2004;164:327\u201332.","journal-title":"Arch Intern Med"},{"key":"1599_CR120","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1056\/NEJM199608153350718","volume":"335","author":"J Kessler","year":"1996","unstructured":"Kessler J, Samuels SC. Sertraline and hyponatremia. N Engl J Med. 1996;335:524\u201334.","journal-title":"N Engl J Med"},{"key":"1599_CR121","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4235\/agmr.21.0062","volume":"25","author":"J Kacperczyk","year":"2021","unstructured":"Kacperczyk J, Perdyan A, Stompor M. Drug-resistant hyponatremia after escitalopram intake: a series of two case reports. Ann Geriatr Med Res. 2021;25:217\u201321.","journal-title":"Ann Geriatr Med Res"},{"key":"1599_CR122","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.encep.2017.09.003","volume":"44","author":"R Revol","year":"2018","unstructured":"Revol R, Rault C, Polard E, Bellet F, Guy C. Hyponatremia associated with SSRI\/NRSI: descriptive and comparative epidemiological study. L\u2019Encephale. 2018;44:291\u20136.","journal-title":"L'Encephale."},{"key":"1599_CR123","first-page":"bcr2014208037-7","volume":"2015","author":"AO Amoako","year":"2015","unstructured":"Amoako AO, Brown C, Riley T. Syndrome of inappropriate antidiuretic hormone secretion: a story of duloxetine-induced hyponatraemia. Case Rep. 2015;2015:bcr2014208037-7.","journal-title":"Case Rep"},{"key":"1599_CR124","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/npr2.12279","volume":"42","author":"A Sato","year":"2022","unstructured":"Sato A, Yasuda N, Oda Y, Yang M, Suzuki Y, Shinozaki M, et al. Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following duloxetine treatment for pain with depression: two case reports. Neuropsychopharmacol Rep. 2022;42:387\u201390.","journal-title":"Neuropsychopharmacol Rep"},{"key":"1599_CR125","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2169\/internalmedicine.2346-18","volume":"58","author":"K Yoshida","year":"2019","unstructured":"Yoshida K, Aburakawa Y, Suzuki Y, Kuroda K, Kimura T. Acute hyponatremia resulting from duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion. Intern Med. 2019;58:1939\u201342.","journal-title":"Intern Med"},{"key":"1599_CR126","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11096-013-9870-0","volume":"36","author":"ED Liew","year":"2014","unstructured":"Liew ED, Alderman CP. Syndrome of inappropriate antidiuretic hormone secretion associated with desvenlafaxine. Int J Clin Pharm. 2014;36:253\u20135.","journal-title":"Int J Clin Pharm"},{"key":"1599_CR127","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","volume":"52","author":"G Liamis","year":"2008","unstructured":"Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008;52:144\u201353.","journal-title":"Am J Kidney Dis"},{"key":"1599_CR128","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","volume":"70","author":"P Zanos","year":"2018","unstructured":"Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018;70:621\u201360.","journal-title":"Pharmacol Rev"},{"key":"1599_CR129","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018;23:801\u201311.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"1599_CR130","volume":"14","author":"K Kumar","year":"2022","unstructured":"Kumar K, Poonam FNU, Rani T, Prinka FNU, Ibeson CE, Nwosu I, et al. Ketamine-induced syndrome of inappropriate antidiuretic hormone secretion and hyponatremia. Cureus. 2022;14(6):e25931.","journal-title":"Cureus"},{"key":"1599_CR131","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12630-022-02221-4","volume":"69","author":"J James","year":"2022","unstructured":"James J, Lau A, Varshney V. Ketamine-precipitated syndrome of inappropriate antidiuretic hormone secretion in a patient with persistent lumbar pain: a case report. Can J Anaesth. 2022;69:624\u20139.","journal-title":"Can J Anaesth"},{"key":"1599_CR132","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1213\/XAA.0000000000001091","volume":"13","author":"BB Shenoda","year":"2019","unstructured":"Shenoda BB, Krevolin LE, Sherman M. Syndrome of inappropriate antidiuretic hormone release during ketamine infusion in complex regional syndrome patient receiving intrathecal baclofen: a case report. A&A Pract. 2019;13:386\u20138.","journal-title":"A&A Pract."},{"key":"1599_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122773","volume":"15","author":"L Boudieu","year":"2023","unstructured":"Boudieu L, Mennetrier M, Llorca P-M, Samalin L. The efficacy and safety of intranasal formulations of ketamine and esketamine for the treatment of major depressive disorder: a systematic review. Pharmaceutics. 2023;15:2773.","journal-title":"Pharmaceutics"},{"issue":"Suppl 2","key":"1599_CR134","first-page":"153","volume":"53","author":"S Majdanik","year":"2007","unstructured":"Majdanik S, Borowiak K, Brzeznska M, Machoy-Mokrzynska A. Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine. Ann Acad Med Stetin. 2007;53(Suppl 2):153\u20138.","journal-title":"Ann Acad Med Stetin"},{"issue":"4","key":"1599_CR135","doi-asserted-by":"publisher","DOI":"10.5812\/ijpbs.8013","volume":"11","author":"F Elyasi","year":"2017","unstructured":"Elyasi F, Azizi M. Concurrent serotonin syndrome and hyponatremia: a case report and review. Iran J Psychiatry Behav Sci. 2017;11(4):e8013.","journal-title":"Iran J Psychiatry Behav Sci"},{"key":"1599_CR136","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780199362585.001.0001","volume-title":"Top drugs: their history, pharmacology, and syntheses","author":"JJ Li","year":"2015","unstructured":"Li JJ. Top drugs: their history, pharmacology, and syntheses. New York: Oxford University Press; 2015."},{"key":"1599_CR137","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","volume":"25","author":"F Bymaster","year":"2001","unstructured":"Bymaster F. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology. 2001;25:871\u201380.","journal-title":"Neuropsychopharmacology"},{"key":"1599_CR138","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/WOX.0b013e3181b35322","volume":"2","author":"P Lieberman","year":"2009","unstructured":"Lieberman P. The role of antihistamines in the treatment of vasomotor rhinitis. World Allergy Organ J. 2009;2:156\u201361.","journal-title":"World Allergy Organ J"},{"key":"1599_CR139","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","volume":"340","author":"M Tatsumi","year":"1997","unstructured":"Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340:249\u201358.","journal-title":"Eur J Pharmacol"},{"key":"1599_CR140","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mehy.2005.12.006","volume":"66","author":"E Hellbom","year":"2006","unstructured":"Hellbom E. Chlorpheniramine, selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter (OTC) treatment. Med Hypotheses. 2006;66:689\u201390.","journal-title":"Med Hypotheses"},{"key":"1599_CR141","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415:198\u2013205.","journal-title":"Nature"},{"key":"1599_CR142","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jemermed.2004.04.006","volume":"27","author":"DB Diercks","year":"2004","unstructured":"Diercks DB, Shumaik GM, Harrigan RA, Brady WJ, Chan TC. Electrocardiographic manifestations: electrolyte abnormalities. J Emerg Med. 2004;27:153\u201360.","journal-title":"J Emerg Med"},{"key":"1599_CR143","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2174\/1573403X15666190306111812","volume":"15","author":"M Rodriguez","year":"2019","unstructured":"Rodriguez M, Hernandez M, Cheungpasitporn W, Kashani KB, Riaz I, Rangaswami J, et al. Hyponatremia in heart failure: pathogenesis and management. Curr Cardiol Rev. 2019;15:252\u201361.","journal-title":"Curr Cardiol Rev"},{"key":"1599_CR144","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMra1404489","volume":"372","author":"RH Sterns","year":"2015","unstructured":"Sterns RH. Disorders of plasma sodium\u2014causes, consequences, and correction. N Engl J Med. 2015;372:55\u201365.","journal-title":"N Engl J Med"},{"key":"1599_CR145","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuroscience.2009.11.074","volume":"168","author":"H Pasantes-Morales","year":"2010","unstructured":"Pasantes-Morales H, Cruz-Rangel S. Brain volume regulation: osmolytes and aquaporin perspectives. Neuroscience. 2010;168:871\u201384.","journal-title":"Neuroscience"},{"key":"1599_CR146","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/gps.367","volume":"16","author":"D Kirby","year":"2001","unstructured":"Kirby D, Ames D. Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry. 2001;16:484\u201393.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"1599_CR147","doi-asserted-by":"publisher","first-page":"197","DOI":"10.15406\/japlr.2018.07.00226","volume":"7","author":"L Galan Martinez","year":"2018","unstructured":"Galan Martinez L, Curbelo Gonzalez GE. Cardiotoxicity of H1-antihistamines. J Anal Pharm Res. 2018;7(2):197\u2013201.","journal-title":"J Anal Pharm Res."},{"key":"1599_CR148","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2009.13.3.215","volume":"13","author":"H-K Hong","year":"2009","unstructured":"Hong H-K, Jo S-H. Block of hERG K+ channel by classic histamine H1 receptor antagonist chlorpheniramine. Korean J Physiol Pharmacol. 2009;13:215.","journal-title":"Korean J Physiol Pharmacol"},{"key":"1599_CR149","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3928\/02793695-20040201-04","volume":"42","author":"DL Finfgeld","year":"2004","unstructured":"Finfgeld DL. Serotonin syndrome and the use of SSRIs. J Psychosoc Nurs Ment Health Serv. 2004;42:16\u201320.","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"1599_CR150","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.genhosppsych.2005.06.008","volume":"28","author":"A Navarro","year":"2006","unstructured":"Navarro A, Perry C, Bobo WV. A case of serotonin syndrome precipitated by abuse of the anticough remedy dextromethorphan in a bipolar patient treated with fluoxetine and lithium. Gen Hosp Psychiatry. 2006;28:78\u201380.","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"1599_CR151","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/14740338.2021.1846717","volume":"20","author":"Z Ali","year":"2021","unstructured":"Ali Z, Ismail M, Khan F, Sajid H. Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System. Expert Opin Drug Saf. 2021;20(1):101\u20138.","journal-title":"Expert Opin Drug Saf"},{"key":"1599_CR152","first-page":"2012","volume":"18","author":"A Grosjean","year":"2022","unstructured":"Grosjean A, Thieffry C, Marti C. Syndrome de demyelinisation osmotique: quelle vitesse de correction de la natremie? Revue Med Suisse. 2022;18:2012\u20138.","journal-title":"Revue Med Suisse."},{"key":"1599_CR153","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/cc11805","volume":"17","author":"C Overgaard-Steensen","year":"2012","unstructured":"Overgaard-Steensen C, Ring T. Clinical review: practical approach to hyponatraemia and hypernatraemia in critically ill patients. Crit Care. 2012;17:206.","journal-title":"Crit Care"},{"issue":"7","key":"1599_CR154","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.sapharm.2019.10.004","volume":"16","author":"D Chiewchantanakit","year":"2020","unstructured":"Chiewchantanakit D, Meakchai A, Pituchaturont N, Dilokthornsakul P, Dhippayom T. The effectiveness of medication reconciliation to prevent medication error: a systematic review and meta-analysis. Res Social Adm Pharm. 2020;16(7):886\u201394.","journal-title":"Res Social Adm Pharm"},{"issue":"9","key":"1599_CR155","first-page":"1139","volume":"81","author":"AZ Ables","year":"2010","unstructured":"Ables AZ, Nagubilli R. Prevention, recognition, and management of serotonin syndrome. Am Fam Physician. 2010;81(9):1139\u201342.","journal-title":"Am Fam Physician"},{"key":"1599_CR156","doi-asserted-by":"publisher","first-page":"1244101","DOI":"10.3389\/fpsyt.2023.1244101","volume":"14","author":"P Scognamiglio","year":"2023","unstructured":"Scognamiglio P, Morena D, Di Fazio N, Delogu G, Iniziato V, La Pia S, et al. Vox clamantis in deserto: a survey among Italian psychiatrists on defensive medicine and professional liability. Front Psychiatry. 2023;14:1244101.","journal-title":"Front Psychiatry."},{"issue":"11","key":"1599_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59111928","volume":"59","author":"D Morena","year":"2023","unstructured":"Morena D, Di Fazio N, Scognamiglio P, Delogu G, Baldari B, Cipolloni L, et al. Predictors of defensive practices among Italian psychiatrists: additional findings from a national survey. Medicina (Kaunas). 2023;59(11):1928.","journal-title":"Medicina (Kaunas)"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01599-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01599-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01599-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:02:04Z","timestamp":1793466124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01599-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":157,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1599"],"URL":"https:\/\/doi.org\/10.1007\/s40261-026-01599-z","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No datasets were generated or analyzed during the current study.","order":4,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conceptualization: Donato Morena and Pasquale Scognamiglio. Investigation: Donato Morena, Letizia Biso, Federico Lucci, and Pasquale Scognamiglio. Writing\u2014original draft: Donato Morena, Letizia Biso, Federico Lucci, and Pasquale Scognamiglio. Writing\u2014review and editing: Matteo Lippi, Emanuela Turillazzi, and Vittorio Fineschi. The final version of this manuscript has been read and approved by the authors of this manuscript.","order":7,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}